589 results on '"Dierickx, Daan"'
Search Results
2. Treatment of Epstein-Barr Virus infection in immunocompromised patients
3. Tabelecleucel for allogeneic haematopoietic stem-cell or solid organ transplant recipients with Epstein–Barr virus-positive post-transplant lymphoproliferative disease after failure of rituximab or rituximab and chemotherapy (ALLELE): a phase 3, multicentre, open-label trial
4. Not all black colons on [18F]FDG PET are due to metformin
5. FDG-PET/CT in Heart Transplant
6. Aberrant MYCN expression drives oncogenic hijacking of EZH2 as a transcriptional activator in peripheral T-cell lymphoma
7. Epidemiology, Outcomes, and Complement Gene Variants in Secondary Thrombotic Microangiopathies
8. Genetic and immunological features of immune deficiency and dysregulation‐associated lymphoproliferations and lymphomas as a basis for classification.
9. Lymphoma Classifications, How to Develop a Future Unified Taxonomy.
10. Policy brief of the Belgian Europe's Beating Cancer Plan mirror group: children, adolescents and young adults with cancer.
11. Single center, real-world retrospective study of CAR-T cell therapy for relapsed/refractory large B-cell lymphoma beyond second line: five-year results at the University Hospitals Leuven.
12. Clinical Features and Diagnostic Considerations
13. Immunotherapy for cancer treatment during pregnancy
14. Immunotherapy Rechallenge after Checkpoint Inhibitor Induced Haemophagocytic Lymphohistiocytosis: a Case Report and Literature Review
15. Comprehensive genome-wide analysis of routine non-invasive test data allows cancer prediction: A single-center retrospective analysis of over 85,000 pregnancies
16. Clinical Presentations and Features of PTLD After HSCT
17. The landscape of copy number variations in classical Hodgkin lymphoma: a joint KU Leuven and LYSA study on cell-free DNA
18. Epstein-Barr virus-associated posttransplant lymphoproliferative disorders: new insights in pathogenesis, classification and treatment
19. Pushing the boundaries. Concurrent Hodgkin lymphoma and breast cancer treatment with preservation of pregnancy: A case report
20. Fusion transcripts FYN-TRAF3IP2 and KHDRBS1-LCK hijack T cell receptor signaling in peripheral T-cell lymphoma, not otherwise specified
21. Obstetric and maternal outcomes in patients diagnosed with Hodgkin lymphoma during pregnancy: a multicentre, retrospective, cohort study
22. In-depth characterization of the tumor microenvironment in central nervous system lymphoma reveals implications for immune-checkpoint therapy
23. P1388: EFFECTIVENESS AND SAFETY OUTCOMES IN PATIENTS WITH EBV+ PTLD TREATED WITH ALLOGENEIC EBV-SPECIFIC T-CELL IMMUNOTHERAPY (TABELECLEUCEL) UNDER AN EXPANDED ACCESS PROGRAM IN EUROPE
24. P1390: NEW AND UPDATED RESULTS FROM A MULTICENTER OPEN-LABEL GLOBAL PHASE3 STUDY OF TAB-CEL FOR EBV+PTLD FOLLOWING HCT OR SOT AFTER FAILURE OF RITUXIMAB OR RITUXIMAB+CHEMOTHERAPY (ALLELE)
25. P1608: REAL-WORLD INSIGHTS ON THE MANAGEMENT OF IMMUNE-MEDIATED THROMBOTIC THROMBOCYTOPENIC PURPURA (ITTP) WITH CAPLACIZUMAB IN BELGIUM
26. Real-world insights on the management of immune-mediated thrombotic thrombocytopenic purpura with caplacizumab
27. Other immunomodulatory agent-related lymphoproliferative diseases: a single-center series of 72 biopsy-confirmed cases
28. Autologous stem-cell transplantation in treatment-refractory Crohn's disease: an analysis of pooled data from the ASTIC trial
29. The role of splenectomy in autoimmune hematological disorders: Outdated or still worth considering?
30. Identification of distinct subgroups of EBV-positive post-transplant diffuse large B-cell lymphoma
31. A Belgian consensus protocol for autologous hematopoietic stem cell transplantation in multiple sclerosis
32. New and Updated Results from a Multicenter, Open-Label, Global Phase 3 (P3) Study of Tabelecleucel (Tab-cel) for Epstein–Barr Virus-Positive Post-Transplant Lymphoproliferative Disease (EBV+ PTLD) Following Allogeneic Hematopoietic Cell (HCT) or Solid Organ Transplant (SOT) after Failure of Rituximab (R) or Rituximab and Chemotherapy (R+CT) (ALLELE)
33. Correction to: In-depth characterization of the tumor microenvironment in central nervous system lymphoma reveals implications for immune-checkpoint therapy
34. How I treat posttransplant lymphoproliferative disorders
35. Bortezomib for refractory autoimmune hemolytic anemia after intestinal transplantation
36. Safety and performance of the Spectra Optia apheresis system for white blood cell depletion in patients with elevated white blood cell counts.
37. Safety and performance of the S pectra O ptia apheresis system for white blood cell depletion in patients with elevated white blood cell counts
38. 3001 – ABERRANT MYCN OVEREXPRESSION DRIVES ONCOGENIC HIJACKING OF EZH2 AS A TRANSCRIPTIONAL ACTIVATOR IN PERIPHERAL T CELL LYMPHOMA.
39. Immunosuppression Is Associated With Clinical Features and Relapse Risk of B Cell Posttransplant Lymphoproliferative Disorder: A Retrospective Analysis Based on the Prospective, International, Multicenter PTLD-1 Trials
40. The role of rituximab in adults with warm antibody autoimmune hemolytic anemia
41. Non-invasive detection of genomic imbalances in Hodgkin/Reed-Sternberg cells in early and advanced stage Hodgkin's lymphoma by sequencing of circulating cell-free DNA: a technical proof-of-principle study
42. Characteristics and Outcome of Post-Transplant Lymphoproliferative Disorders After Solid Organ Transplantation: A Single Center Experience of 196 Patients Over 30 Years
43. New and Updated Results from a Multicenter, Open-Label, Global Phase 3 Study of Tabelecleucel (Tab-cel) for Epstein-Barr Virus-Positive Post-Transplant Lymphoproliferative Disease (EBV+ PTLD) Following Allogeneic Hematopoietic Cell (HCT) or Solid Organ Transplant (SOT) after Failure of Rituximab or Rituximab and Chemotherapy (ALLELE)
44. Consolidation Improves Survival in Primary Central Nervous System Lymphoma without Preference for Type of High-Dose Methotrexate-Based Induction Treatment Regimen
45. Blinatumomab in relapsed/refractory diffuse large B cell lymphoma
46. De novo thrombotic microangiopathy after non-renal solid organ transplantation
47. [18F]FDG-PET/CT volumetric parameters can predict outcome in untreated mantle cell lymphoma
48. Post-Transplantation Lymphoproliferative Disorders in Adults
49. Blood smear and fluorescence based platelet count are key in a case of cryoglobulin masked thrombocytopenia.
50. Secondary B-cell lymphoma associated with the Epstein-Barr virus in chronic lymphocytic leukemia patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.